RESUMO
Numerous studies have been published which, separately, investigate the influence of molecular features on oncological and cardiac pathologies. Nevertheless, the relationship between both families of diseases at the molecular level is an emerging area within onco-cardiology/cardio-oncology. This paper presents a new open-source database that aims to organize the curated information concerning the molecular features validated in patients involved in both cancer and cardiovascular diseases. Entities like gene, variation, drug, study and others are modelled as objects of a database which is populated with curated information from 83 papers identified by systematic literature searched for up to 2021. Researchers will discover new connections among them to validate hypotheses or suggest new ones. Special care has been taken to use standard nomenclature for genes, pathologies and all the objects for which accepted conventions exist. The database can be consulted via the web with a system of simplified queries, but it also accepts any query. It will be updated and refined with the incorporation of new studies as they become available. Database URL http://biodb.uv.es/oncocardio/.
Assuntos
Cardiologia , Doenças Cardiovasculares , Neoplasias , Humanos , Oncologia , Neoplasias/genética , Doenças Cardiovasculares/genética , Bases de Dados FactuaisRESUMO
Introduction: Tuberculosis (TB) is now the 2nd leading infectious killer after COVID-19 and the 13th leading cause of death worldwide. Moreover, TB is a lethal combination for HIV-patients. Th1 responses and particularly IFN-γ are crucial for immune protection against Mycobacterium tuberculosis infection. Many gene variants for IFNG that confer susceptibility to TB have been described in multiple ethnic populations. Likewise, some epigenetic modifications have been evaluated, being CpG methylation the major epigenetic mark that makes chromatin inaccessible to transcription factors, thus avoiding the initiation of IFNG transcription. Methods: We evaluated both genetic and epigenetic changes involved in IFN-γ production and TB susceptibility in Argentine population. Amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) was performed for the IFN-γ +874 A/T polymorphism (rs2430561) genotyping in 199 healthy donors (HD) and 173 tuberculosis (TB) patients. IFN-γ levels from M. tuberculosis-stimulated PBMCs were measured by ELISA. The methylation status at the -53 CpG site of the IFNG promoter in individuals with latent infection (LTBI), TB and HD was determine by pyrosequencing. Results: Using a case-control study, we found that A allele and, consequently, AA genotype were overrepresented in patients with active disease. Moreover, HD carrying T allele (AT or TT genotype) evidenced an augmented IFN-γ secretion compared to TB patients. Codominance was the genetic model that best fits our results according to the Akaike information criterion (AIC). In addition, increased methylation levels at the -53 CpG site in the IFN-γ promoter were observed in whole blood of patients with active TB compared to LTBI individuals. Discussion: IFN-γ is regulated by genetic variants and epigenetic modifications during TB. Besides, AA genotype of the rs2430561 single nucleotide polymorphism could be considered as a potential TB susceptibility genetic biomarker in Argentina and the methylation of the -53 CpG site could result in a useful predictor of TB reactivation.
Assuntos
COVID-19 , Interferon gama , Mycobacterium tuberculosis , Tuberculose , Humanos , Estudos de Casos e Controles , Predisposição Genética para Doença , Genótipo , Interferon gama/genética , Polimorfismo de Nucleotídeo Único , Tuberculose/genéticaRESUMO
El coriocarcinoma es un tumor de la placenta agresivo y poco frecuente que forma parte de las denominadas enfermedades trofoblásticas gestacionales. Presentamos el caso de una mujer de 22 años nulípara que, en el transcurso del embarazo, en la semana 34, presenta metrorragia con hemoptisis de forma espontánea. Se realiza una tomografía computarizada en la que se aprecian nódulos compatibles con metástasis, catalogándose como posible coriocarcinoma metastásico. Se programa para cesárea preferente y se inicia tratamiento quimioterápico. Este tumor es muy sensible a la quimioterapia y presenta un alto índice de supervivencia, aunque en los casos metastásicos puede ser mortal.Choriocarcinoma is a rare, aggressive placental tumor that is part of so-called gestational trophoblastic diseases. We present the case of a 22-year-old nulliparous woman who spontaneously presents metrorrhagia with hemoptysis in the course of pregnancy at the 34th week. A tomography scan is performed to confirm nodules compatible with metastasis, cataloguing it as a possible metastatic choriocarcinoma. A cesarean section is preferably scheduled and treatment with chemotherapy is initiated. Choriocarcinoma is a tumor very sensitive to chemotherapy and has a high survival rate, although in metastatic cases the disease is usually fatal.
Assuntos
Cesárea , Placenta , Adulto , Feminino , Humanos , Gravidez , Estudos Retrospectivos , Taxa de Sobrevida , Adulto JovemRESUMO
Prostaglandin E2 (PGE2), an active lipid compound derived from arachidonic acid, regulates different stages of the immune response of the host during several pathologies such as chronic infections or cancer. In fact, manipulation of PGE2 levels was proposed as an approach for countering the Type I IFN signature of tuberculosis (TB). However, very limited information regarding the PGE2 pathway in patients with active TB is currently available. In the present work, we demonstrated that PGE2 exerts a potent immunosuppressive action during the immune response of the human host against Mycobacterium tuberculosis (Mtb) infection. Actually, we showed that PGE2 significantly reduced the surface expression of several immunological receptors, the lymphoproliferation and the production of proinflammatory cytokines. In addition, PGE2 promoted autophagy in monocytes and neutrophils cultured with Mtb antigens. These results suggest that PGE2 might be attenuating the excessive inflammatory immune response caused by Mtb, emerging as an attractive therapeutic target. Taken together, our findings contribute to the knowledge of the role of PGE2 in the human host resistance to Mtb and highlight the potential of this lipid mediator as a tool to improve anti-TB treatment.
Assuntos
Dinoprostona/farmacologia , Imunossupressores/farmacologia , Monócitos/imunologia , Mycobacterium tuberculosis/imunologia , Neutrófilos/imunologia , Tuberculose/imunologia , Adulto , Dinoprostona/imunologia , Feminino , Humanos , Imunossupressores/imunologia , MasculinoRESUMO
Th17 lymphocytes, that produce IL17A, IL17F, and IL22, play a crucial role during the immune response against Mycobacterium tuberculosis (Mtb) infection. Whereas, the contribution of IL17A in immunity to tuberculosis is usually accepted, the role of IL17F has been scarcely studied so far. The aim of this work was to evaluate the existence of a potential association of the non-synonymous variant rs763780 SNP of the IL17F gene with human tuberculosis. Accordingly, by comparing healthy donors (HD) and tuberculosis patients (TB) populations we demonstrated an association between the C allele of the SNP and the susceptibility to tuberculosis disease in Argentina. Furthermore, we found that peripheral blood mononuclear cells (PBMCs) from individuals with a more effective immune response against Mtb secreted the highest levels of IL17F when stimulated with a lysate of Mtb (Mtb-Ag). Besides, we evidenced that Mtb-Ag-stimulated PBMCs from HD carrying the C variant of the SNP displayed the lowest IFNG secretion, proliferation index, and SLAM expression as compared to TT carriers. Moreover, Mtb-Ag-stimulated PBMCs from TB carrying the C allele produced the lowest levels of IFNG, the highest level of IL17A, and the minimum proliferation indexes as compared to TT TB, suggesting a relationship between the C allele and tuberculosis severity. In fact, TB carrying the C allele presented a more severe disease, with the highest bacilli burden in sputum. Together, our findings identify the IL17F rs763780 SNP as a biomarker of tuberculosis susceptibility and advanced disease severity in Argentina, suggesting that IL17F could be a critical cytokine in tuberculosis immunity.
Assuntos
Predisposição Genética para Doença/genética , Interleucina-17/genética , Polimorfismo de Nucleotídeo Único/genética , Tuberculose/genética , Adulto , Alelos , Argentina , Estudos de Casos e Controles , Feminino , Frequência do Gene/genética , Genótipo , Heterozigoto , Humanos , Leucócitos Mononucleares , Masculino , Mycobacterium tuberculosis/patogenicidadeAssuntos
Diarreia/etiologia , Giardíase/complicações , Síndrome do Intestino Irritável/complicações , Adulto , Antiprotozoários/uso terapêutico , Biópsia , Diagnóstico Tardio , Diagnóstico Diferencial , Diarreia/tratamento farmacológico , Duodenoscopia , Duodeno/parasitologia , Duodeno/patologia , Feminino , Gastroenterite/etiologia , Giardia lamblia/isolamento & purificação , Giardíase/diagnóstico , Giardíase/tratamento farmacológico , Humanos , Síndrome do Intestino Irritável/diagnóstico , México , Paroxetina/uso terapêutico , Reação em Cadeia da Polimerase , Tinidazol/uso terapêutico , Doença Relacionada a ViagensRESUMO
During mycobacterial infection, macroautophagy/autophagy, a process modulated by cytokines, is essential for mounting successful host responses. Autophagy collaborates with human immune responses against Mycobacterium tuberculosis (Mt) in association with specific IFNG secreted against the pathogen. However, IFNG alone is not sufficient to the complete bacterial eradication, and other cytokines might be required. Actually, induction of Th1 and Th17 immune responses are required for protection against Mt. Accordingly, we showed that IL17A and IFNG expression in lymphocytes from tuberculosis patients correlates with disease severity. Here we investigate the role of IFNG and IL17A during autophagy in monocytes infected with Mt H37Rv or the mutant MtΔRD1. Patients with active disease were classified as high responder (HR) or low responder (LR) according to their T cell responses against Mt. IL17A augmented autophagy in infected monocytes from HR patients through a mechanism that activated MAPK1/ERK2-MAPK3/ERK1 but, during infection of monocytes from LR patients, IL17A had no effect on the autophagic response. In contrast, addition of IFNG to infected monocytes, increased autophagy by activating MAPK14/p38 α both in HR and LR patients. Interestingly, proteins codified in the RD1 region did not interfere with IFNG and IL17A autophagy induction. Therefore, in severe tuberculosis patients' monocytes, IL17A was unable to augment autophagy because of a defect in the MAPK1/3 signaling pathway. In contrast, both IFNG and IL17A increased autophagy levels in patients with strong immunity to Mt, promoting mycobacterial killing. Our findings might contribute to recognize new targets for the development of novel therapeutic tools to fight the pathogen.
Assuntos
Autofagia , Interleucina-17/fisiologia , Monócitos/imunologia , Tuberculose/imunologia , Células Cultivadas , Humanos , Interferon gama/fisiologia , Monócitos/microbiologia , Mycobacterium tuberculosis/fisiologia , Transdução de Sinais , Tuberculose/diagnóstico , Tuberculose/microbiologiaRESUMO
In this case the standard automatic trimentional reconstruction of helical CT scan overestimated the extent of chest wall invasion by a lung tumor. MRI gave a better definition and surgical excision with good gross microscopical margins could be performed. Retrospectively, slice by slice free-hand function tridimentional reconstruction of stored helical CT scan images resulted closer to reality. A word of caution is advised to avoid therapeutic mistakes.